Trial intelligence / Profile preview

Linezolid pharmacokinetics in healthy Chinese volunteers

ChiCTR-ONRC-10000751Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of linezolid in Gram-positive bacterial infection (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Plasma drug concentration. Started Jan 2010; status: completed.

02

Drugs

linezolid
03

Conditions

Gram-positive bacterial infection

Beyond the preview

Go deeper on ChiCTR-ONRC-10000751.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONRC-10000751.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call